Blood and bone marrow dosimetry for thyroid cancer patients prepared with rhTSH injection
This study validated the feasibility of using dosimetry in euthyroid patients to predict therapeutic <sup>131</sup>I biokinetics in DTC patients prepared with rhTSH.
Authors
- Jennie Cooke
- Amna Juma Al-Jabri (ORCID: https://orcid.org/0009-0003-8885-2856)
- Seán Cournane (ORCID: https://orcid.org/0000-0002-8185-968X)
- Marie‐Louise Healy
Institutions
- Trinity College Dublin (IE)
- Children's Health Ireland at Crumlin (IE)
- St. Vincent's University Hospital (IE)
- St. James's Hospital (IE)
- Sultan Qaboos University (OM)
Publication Details
- Journal
- Annals of Nuclear Medicine
- Published
- 2025-04-05
- DOI
- https://doi.org/10.1007/s12149-025-02042-7
- Primary Topic
- Thyroid Cancer Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Ministry of Higher Education, Research and Innovation